Immunoproteomic identification of biotransformed self-proteins from the livers of female Balb/c mice following chronic ethanol administration

Proteomics

Volumn 12, Issue 12, 2012, Pages 2036-2044

  Kaur, Inderjeet ^a   Katyal, Anju ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Animal proteomics; Autoantigens; Liver disease; MALDI TOF; Malondialdehyde and MAA adducts; Subcellular fractionation

Indexed keywords

ALCOHOL; CYTOSKELETON PROTEIN; GLUTATHIONE TRANSFERASE; LIVER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; CYTOSOL; FATTY LIVER; FEMALE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIVER; LIVER METABOLISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROSOME; MITOCHONDRION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS;

ACETIC ACID; ANIMALS; CYTOSOL; ETHANOL; FEMALE; GLUTATHIONE; HEPATITIS, ALCOHOLIC; HISTOCYTOCHEMISTRY; IMMUNOBLOTTING; LIVER; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; MICROSOMES, LIVER; MITOCHONDRIA; PROTEOME; PROTEOMICS;

ANIMALIA; MUS;

EID: 84862991226     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100105     Document Type: Article

References (38)

1. Kamimura, S., Gaal, K., Britton, R. S., Bacon, B. R. et al., Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992, 16, 448-453.
2. Chen, J., Petersen, D. R., Schenker, S., Henderson, G. I., Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome C oxidase. Alcohol Clin. Exp. Res. 2000, 24, 544-552.
3. Nicholls, R., De Jersey, J., Worrall, S., Wilce, P., Modification of proteins and other biological molecules by acetaldehyde: adduct structure and functional significance. Int. J. Biochem. 1992, 24, 1899-1906.
4. Tuma, D. J., Hoffmann, T., Sorrell, M. F., The chemistry of acetaldehyde-protein adducts. Alcohol Alcohol. Suppl. 1991, 1, 271-276.
5. Kikugawa, K., Beppu, M., Involvement of lipid oxidation products in the formation of fluorescent and cross-linked proteins. Chem. Phys. Lipids 1987, 44, 277-296.
6. Uchida, K., Szweda, L. I., Chae, H. Z., Stadtman, E. R., Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA 1993, 90, 8742-8746.
7. Sorrell, M. F., Tuma, D. J., Hypothesis: alcoholic liver injury and the covalent binding of acetaldehyde. Alcohol Clin. Exp. Res. 1985, 9, 306-309.
8. Tuma, D. J., Newman, M. R., Donohue, T. M., Jr., Sorrell, M. F., Covalent binding of acetaldehyde to proteins: participation of lysine residues. Alcohol Clin. Exp. Res. 1987, 11, 579-584.
9. Duryee, M. J., Willis, M. S., Freeman, T. L., Kuszynski, C. A. et al., Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci. 2004, 1, 3145-3155.
10. Thiele, G. M., Freeman, T. L., Klassen, L. W., Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis. 2004, 24, 273-287.
11. Tuma, D. J., Klassen, L. W., Immune responses to acetaldehyde protein adducts: role in alcoholic liver disease. Gastroenterology 1992, 103, 1969-1973.
12. Niemela, O., Parkkila, S., Yla-Herttuala, S., Villanueva J. et al., Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology 1995, 22, 1208-1214.
13. Willis, M. S., Thiele, G. M., Tuma, D. J., Klassen, L. W., T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int. Immunopharmacol. 2003, 3, 1381-1399.
14. Thiele, G. M., Tuma, D. J., Willis, M. S., Miller, J. A. et al., Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol Clin. Exp. Res. 1998, 22, 1731-1739.
15. Bradford, M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 1976, 72, 248-254.
16. Rahman, I., Kode, A., Biswas, S. K., Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat. Protoc. 2006, 1, 3159-3165.
17. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
18. Kikugawa, K., Ido, Y., Studies on peroxidized lipids. V. Formation and characterization of 1, 4-dihydropyridine-3, 5-dicarbaldehydes as model of fluorescent components in lipofusion. Lipids 1984, 19, 600-608.
19. Tuma, D. J., Thiele, G. M., Xu, D., Klassen, L. W. et al., Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 1996, 23, 872-880.
20. Xu, D., Thiele, G. M., Beckenhauer, J. L., Klassen, L. W. et al., Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats. Gastroenterology 1998, 115, 686-692.
21. Rolla, R., Vay, D., Mottaran, E., Parodi, M. et al., Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 2000, 31, 878-884.
22. Duryee, M. J., Klassen, L. W., Thiele, G. M., Immunological response in alcoholic liver disease. World J. Gastroenterol. 2007, 13, 4938-4946.
23. Niemela, O., Juvonen, T., Parkkila, S., Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J. Clin. Invest. 1991, 87, 1367-1374.
24. Han, D., Hanawa, N., Behnam, B., Kaplowitz, N., Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291, G1-G7.
25. Albano, E., Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 2006, 65, 278-290.
26. Ma, Y., Meregalli, M., Hodges, S., Davies, N. et al., Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease. Int. J. Immunopathol. Pharmacol. 2005, 18, 173-182.
27. You, M., Fischer, M., Deeg, M. A., Crabb, W. C. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element binding protein (SREBP). J. Biol. Chem. 2002, 277, 29342-29427.
28. Aguilera, I., Wichmann, I., Sousa, J. M., Bernardos, A. et al., Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin. Exp. Immunol. 2001, 126, 535-539.
29. Husson, A., Brasse-Lagnel, C., Fairand, A., Renouf, S. et al., Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur. J. Biochem. 2001, 270, 1887-1899.
30. Lytton, S. D., Helander, A., Zhang-Gouillon, Z. Q., Stokkeland, K. et al., Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. Mol. Pharmacol. 1999, 55, 223-233.
31. Behrens, U. J., Vernace, S., Paronetto, F., Studies on "liver-specific" antigens. II. Detection of serum antibodies to liver and kidney cell membrane antigens in patients with chronic liver disease. Gastroenterology 1979, 77, 1053-1061.
32. Perperas, A., Tsantoulas, D., Portmann, B., Eddleston, A. L. et al., Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981, 22, 149-152.
33. Bendtsen, P., Hannestad, U., Påhlsson, P., Evaluation of the carbon 13-labeled ketoisocaproate breath test to assess mitochondrial dysfunction in patients with high alcohol consumption. Alcohol Clin. Exp. Res. 1998, 22, 1792-1795.
34. Song, B. J., Moon, K. H., Olsson, N. U., Salem, N. Jr., et al., Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids. J. Hepatol. 2008, 49 (2), 262-273.
35. Duryee, M. J., Klassen, L. W., Schaffert, C. S., Tuma, D. J. et al., Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic. Biol. Med. 2010, 49, 1480-1486.
36. Thiele, G. M., Duryee, M. J., Willis, M. S., Tuma, D. J. et al., Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin. Exp. Res. 2010, 34 (12), 2126-2136.
37. Bootorabi, F., Jänis, J., Valjakka, J., Isoniemi, S. et al., Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity. BMC Biochem. 2008, 9 (32).
38. Rouach, H., Andraud, E., Aufrère, G., Beaugé, F., The effects of acetaldehyde in vitro on proteasome activities and its potential involvement after alcoholization of rats by inhalation of ethanol vapours. Alcohol Alcohol 2005, 40, 359-366.